Active Filters

  • (-) Keywords = mesothelioma
Search Results 1 - 3 of 3
  • RSS Feed
Select Page
Computed tomography, positron emission tomography, positron emission tomography/computed tomography, and magnetic resonance imaging for staging of limited pleural mesothelioma: initial results
Plathow, C., Staab, A., Schmaehl, A., Aschoff, P., Zuna, I., Pfannenberg, C., … Klopp, M. (2008). Computed tomography, positron emission tomography, positron emission tomography/computed tomography, and magnetic resonance imaging for staging of limited pleural mesothelioma: initial results. Investigative Radiology, 43(10), 737-744. https://doi.org/10.1097/RLI.0b013e3181817b3d
Proton therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy
Krayenbuehl, J., Hartmann, M., Lomax, A. J., Kloeck, S., Hug, E. B., & Ciernik, I. F. (2010). Proton therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy. International Journal of Radiation Oncology Biology Physics, 78(2), 628-634. https://doi.org/10.1016/j.ijrobp.2009.11.006
The novel potent TEAD inhibitor, K-975, inhibits YAP1/TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural mesothelioma
Kaneda, A., Seike, T., Danjo, T., Nakajima, T., Otsubo, N., Yamaguchi, D., … Mori, K. (2020). The novel potent TEAD inhibitor, K-975, inhibits YAP1/TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural mesothelioma. American Journal of Cancer Research, 10(12), 4399-4415.